CFD
DAWN

Creative Financial Designs’s Day One Biopharmaceuticals DAWN Stock Holding History

Creative Financial Designs’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$429 Buy
+20
New +$282 ﹤0.01% 2017

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Creative Financial Designs's DAWN Position: Q1 2026 in Review

Creative Financial Designs opened a new position in Day One Biopharmaceuticals (DAWN) in Q1 2026: 20 shares worth $429. The stake represents ﹤0.01% of the portfolio and ranks #2017 among its holdings.

206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Creative Financial Designs held 20 shares of Day One Biopharmaceuticals worth $429 as of Q1 2026.
  • Day One Biopharmaceuticals was a new Creative Financial Designs position in Q1 2026.
  • Day One Biopharmaceuticals made up ﹤0.01% of Creative Financial Designs's portfolio in Q1 2026, its #2017 holding.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.